Atlas Trials

Mesenchymal Stem Cell Therapy in Diabetic Kidney Disease-A Double-blind, Placebo-controlled, Randomized Clinical Trial

Clinical trial NCT07039318 · COMPLETED

Trial details

NCT number
NCT07039318
Sponsor
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Kidney Disease
Start date
2022-12-01
Primary completion
2025-02-28
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.